Your browser doesn't support javascript.
loading
Cytomorphometric Evaluation of Oral Mucosa of Patients with Duchenne Muscular Dystrophy.
Macedo, Débora S; Jacomo, Thierry S; Moraes, Bruna; Ortega, Karem L; Braz-Silva, Paulo H; Zonta, Marco A; Pallos, Debora; Martins, Fabiana.
Afiliação
  • Macedo DS; School of Dentistry, University of Santo Amaro, Rua Professor Enéas de Siqueira Neto 340, Jardim das Imbuias, São Paulo, Brazil.
  • Jacomo TS; School of Dentistry, University of Santo Amaro, Rua Professor Enéas de Siqueira Neto 340, Jardim das Imbuias, São Paulo, Brazil.
  • Moraes B; School of Dentistry, University of Santo Amaro, Rua Professor Enéas de Siqueira Neto 340, Jardim das Imbuias, São Paulo, Brazil.
  • Ortega KL; Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Braz-Silva PH; Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Zonta MA; Laboratory of Virology, Institute of Tropical Medicine of São Paulo, School of Medicine, University of São Paulo, São Paulo, Brazil.
  • Pallos D; Diagnosis Research and Development S.A, São Paulo, Brazil.
  • Martins F; School of Dentistry, University of Santo Amaro, Rua Professor Enéas de Siqueira Neto 340, Jardim das Imbuias, São Paulo, Brazil.
Head Neck Pathol ; 16(3): 703-706, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35064903
Duchenne muscular dystrophy (DMD) is a rare genetic disorder in which patients progressive muscle deterioration and low life expectancy. Since DMD has no cure, treatment slows the deterioration process using corticosteroids and other medications, including oral bisphosphonates (BP). These drugs can lead to toxicities in both soft and hard tissues. The objective of this study was to present cytological changes in DMD patients, comparing to young, healthy individuals. Cytological smears were obtained from buccal mucosa from nine DMD patients and five healthy patients. The Papanicolaou technique was used to stain the slides. Images were captured using a photomicroscope, and 50 clearly defined cells were selected. The size and ratio between the nucleus and cytoplasmic areas (NA/CA) diameter were measured using a computer program. All the DMD patients presented a statistical difference (p < 0.0001) in the size of the cytoplasm (0.60 ± 0.33 µm) and the NA/CA ratio (0.17 ± 0.07 µm) was seen when compared to the control group (cytoplasm 0.60 ± 0.15 µm and nucleus 0.14 ± 0.05 µm). Furthermore, in one DMD in use of BP who presented Medication-Related Osteonecrosis of the Jaw (MRONJ), presented higher differences in the cytoplasmic (1.20 ± 0.65 µm) and nuclear (0.20 ± 0.12 µm) sizes (p < 0.0001) compared with all others DMD patients. These results suggest that the drugs used or the systemic condition of individuals with DMD may contribute to these changes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofia Muscular de Duchenne Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Head Neck Pathol Assunto da revista: NEOPLASIAS / PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofia Muscular de Duchenne Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Head Neck Pathol Assunto da revista: NEOPLASIAS / PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos